Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery
Authors
Keywords
-
Journal
JAMA Surgery
Volume 158, Issue 10, Pages 1003
Publisher
American Medical Association (AMA)
Online
2023-07-27
DOI
10.1001/jamasurg.2023.2930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes
- (2022) Domenica M. Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes
- (2022) Wahiba Elhag et al. OBESITY SURGERY
- Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis
- (2022) Sophie L van Veldhuisen et al. EUROPEAN HEART JOURNAL
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
- (2022) W. Timothy Garvey et al. NATURE MEDICINE
- Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials
- (2022) Qiucen Lin et al. Expert Review of Clinical Pharmacology
- Use of Weight Loss Medications in Patients after Bariatric Surgery
- (2021) Ilana P. Redmond et al. Current Obesity Reports
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
- (2021) Dimitris Papamargaritis et al. Nutrients
- Prevalence of insufficient weight loss 5 years after Roux-en-Y gastric bypass: metabolic consequences and prediction estimates: a prospective registry study
- (2021) Markus Brissman et al. BMJ Open
- Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants
- (2021) Nicholas L Syn et al. LANCET
- Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
- (2019) Alexander Dimitri Miras et al. Lancet Diabetes & Endocrinology
- Unknown
- (2018) DIABETIC MEDICINE
- Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity
- (2018) Ralph Peterli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Weight and Metabolic Outcomes 12 Years after Gastric Bypass
- (2017) Ted D. Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early postoperative weight loss predicts maximal weight loss after sleeve gastrectomy and Roux-en-Y gastric bypass
- (2014) Sean Manning et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now